By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Spherix (Formerly Known As Biospherics Incorporated) 

12051 Indian Creek Court

Beltsville  Maryland  20705  U.S.A.
Phone: 301-419-3900 Fax: 301-419-2344


Company News
Spherix (SPEX) Announces Definitive Terms Reached To Acquire Controlling Interest In Hoth Therapeutics, A Biopharmaceutical Company Developing Its BioLexa Platform To Treat Skin Illness Such As Eczema 6/20/2017 6:41:22 AM
Spherix (SPEX) Announces Economic Interest Acquired In New Patent Portfolio 4/19/2017 8:43:50 AM
Spherix (SPEX) Announces New Clients In The $100B Online Learning Business 2/21/2017 10:41:46 AM
Spherix (SPEX) Release: Company Updates Shareholders 1/23/2017 10:22:22 AM
New Patent Infringement Lawsuit Filed Against Alcatel-Lucent Under Spherix (SPEX) Collaboration Agreement 12/5/2016 6:31:24 AM
Spherix (SPEX) Announces Changes To Board Of Directors 10/31/2016 9:05:38 AM
Spherix (SPEX) Launches New Patent Licensing Initiative 10/19/2016 10:33:41 AM
Spherix (SPEX) Provides Update On Patent Infringement Litigation 10/17/2016 8:26:27 AM
Spherix (SPEX) Issues Letter To Shareholders 9/14/2016 7:16:58 AM
Spherix (SPEX) Awarded Phase II National Science Foundation SBIR Grant To Support Commercialization Of Total Holographic Characterization 9/7/2016 9:22:28 AM